1117803

AcelRx Pharmaceuticals, Inc. — FEI 3006386491

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 13, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hayward, CA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)